Skip to content

Alpha Cognition ACOG Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's warrants and rights outstanding?
Alpha Cognition (ACOG) reported warrants and rights outstanding of 1.6M in Q1 2026.
What does warrants and rights outstanding mean?
The total volume of warrants and rights currently held by investors that grant the right to purchase company stock at a specified price. This figure represents a potential future claim on equity and is a vital component of the company's fully diluted capitalization. Monitoring this helps investors assess the risk of future share dilution.